Literature DB >> 24872592

Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.

Marta J Gonzalez-Hernandez1, James D Cavalcoli2, Maureen A Sartor3, Rafael Contreras-Galindo4, Fan Meng5, Manhong Dai5, Derek Dube4, Anjan K Saha4, Scott D Gitlin6, Gilbert S Omenn7, Mark H Kaplan4, David M Markovitz8.   

Abstract

UNLABELLED: Approximately 8% of the human genome is made up of endogenous retroviral sequences. As the HIV-1 Tat protein activates the overall expression of the human endogenous retrovirus type K (HERV-K) (HML-2), we used next-generation sequencing to determine which of the 91 currently annotated HERV-K (HML-2) proviruses are regulated by Tat. Transcriptome sequencing of total RNA isolated from Tat- and vehicle-treated peripheral blood lymphocytes from a healthy donor showed that Tat significantly activates expression of 26 unique HERV-K (HML-2) proviruses, silences 12, and does not significantly alter the expression of the remaining proviruses. Quantitative reverse transcription-PCR validation of the sequencing data was performed on Tat-treated PBLs of seven donors using provirus-specific primers and corroborated the results with a substantial degree of quantitative similarity. IMPORTANCE: The expression of HERV-K (HML-2) is tightly regulated but becomes markedly increased following infection with HIV-1, in part due to the HIV-1 Tat protein. The findings reported here demonstrate the complexity of the genome-wide regulation of HERV-K (HML-2) expression by Tat. This work also demonstrates that although HERV-K (HML-2) proviruses in the human genome are highly similar in terms of DNA sequence, modulation of the expression of specific proviruses in a given biological situation can be ascertained using next-generation sequencing and bioinformatics analysis.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24872592      PMCID: PMC4136263          DOI: 10.1128/JVI.00556-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  An almost-intact human endogenous retrovirus K on human chromosome 7.

Authors:  J Mayer; M Sauter; A Rácz; D Scherer; N Mueller-Lantzsch; E Meese
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

2.  Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat.

Authors:  Chava B Pocernich; H Fai Poon; Debra Boyd-Kimball; Bert C Lynn; Avindra Nath; Jon B Klein; D Allan Butterfield
Journal:  Brain Res Mol Brain Res       Date:  2005-02-18

3.  Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.

Authors:  B Berkhout; M Jebbink; J Zsíros
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Interval estimation for the difference between independent proportions: comparison of eleven methods.

Authors:  R G Newcombe
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

5.  Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray.

Authors:  Wolfgang Seifarth; Oliver Frank; Udo Zeilfelder; Birgit Spiess; Alex D Greenwood; Rüdiger Hehlmann; Christine Leib-Mösch
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation.

Authors:  C Hohenadl; H Germaier; M Walchner; M Hagenhofer; M Herrmann; M Stürzl; P Kind; R Hehlmann; V Erfle; C Leib-Mösch
Journal:  J Invest Dermatol       Date:  1999-10       Impact factor: 8.551

7.  Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells.

Authors:  K Katsumata; H Ikeda; M Sato; A Ishizu; Y Kawarada; H Kato; A Wakisaka; T Koike; T Yoshiki
Journal:  Clin Immunol       Date:  1999-10       Impact factor: 3.969

8.  Expression analyses of human endogenous retroviruses (HERVs): tissue-specific and developmental stage-dependent expression of HERVs.

Authors:  Goichi Okahara; Shinobu Matsubara; Takaya Oda; Jun Sugimoto; Yoshihiro Jinno; Fuminori Kanaya
Journal:  Genomics       Date:  2004-12       Impact factor: 5.736

9.  Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.

Authors:  M Barbulescu; G Turner; M I Seaman; A S Deinard; K K Kidd; J Lenz
Journal:  Curr Biol       Date:  1999-08-26       Impact factor: 10.834

Review 10.  Retrovirus-associated rheumatic syndromes.

Authors:  M Herrmann; M Neidhart; S Gay; M Hagenhofer; J R Kalden
Journal:  Curr Opin Rheumatol       Date:  1998-07       Impact factor: 5.006

View more
  37 in total

Review 1.  Underlying mechanisms of HIV-1 latency.

Authors:  Bizhan Romani; Elham Allahbakhshi
Journal:  Virus Genes       Date:  2017-03-03       Impact factor: 2.332

Review 2.  Immune responses to endogenous retroelements: taking the bad with the good.

Authors:  George Kassiotis; Jonathan P Stoye
Journal:  Nat Rev Immunol       Date:  2016-04       Impact factor: 53.106

3.  HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA.

Authors:  Laurie R Gray; Rachel E Jackson; Patrick E H Jackson; Stefan Bekiranov; David Rekosh; Marie-Louise Hammarskjöld
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

4.  Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy.

Authors:  Robert W Link; Michael R Nonnemacher; Brian Wigdahl; Will Dampier
Journal:  CRISPR J       Date:  2018-08

5.  HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure.

Authors:  Will Dampier; Michael R Nonnemacher; Neil T Sullivan; Jeffrey M Jacobson; Brian Wigdahl
Journal:  MOJ Immunol       Date:  2014-10-17

6.  Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Derek Dube; Marta J Gonzalez-Hernandez; Susana Chan; Fan Meng; Manhong Dai; Gilbert S Omenn; Scott D Gitlin; David M Markovitz
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 7.  HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.

Authors:  Virginia Carroll; Alfredo Garzino-Demo
Journal:  Pathog Dis       Date:  2015-06-29       Impact factor: 3.166

8.  Mechanisms of HERV-K (HML-2) Transcription during Human Mammary Epithelial Cell Transformation.

Authors:  Meagan Montesion; Neeru Bhardwaj; Zachary H Williams; Charlotte Kuperwasser; John M Coffin
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

9.  HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy.

Authors:  Lauren N Bowen; Richa Tyagi; Wenxue Li; Tariq Alfahad; Bryan Smith; Mary Wright; Elyse J Singer; Avindra Nath
Journal:  Neurology       Date:  2016-09-24       Impact factor: 9.910

10.  Endogenous retroviruses mobilized during friend murine leukemia virus infection.

Authors:  Stefano Boi; Kyle Rosenke; Ethan Hansen; Duncan Hendrick; Frank Malik; Leonard H Evans
Journal:  Virology       Date:  2016-09-19       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.